Jose Ricardo McFaline Figueroa, M.D.,Ph.D.
Title Instructor in Neurology Institution Dana-Farber Cancer Institute Address Dana-Farber Cancer Institute
Center for Neuro-Oncology
450 Brookline Ave
Boston MA 02215
|
|
Biography
| University of Puerto Rico at Mayaguez, Mayaguez, PR | BS | | Chemistry |
| Columbia University in the City of New York, New York, NY | MD, PhD | | Medicine and Cellular Biology |
| Massachusetts General Hospital, Boston, MA | | | Intern in Intermal Medicine |
| Brigham and Women's Hospital/Massachusetts General Hospital, Boston, MA | | | Resident in Neurology |
| Massachusetts General Hospital/Dana-Farber Cancer Institute, Boston, MA | | | Fellow in Neuro-Oncology |
| Harvard T.H. Chan School of Public Health, Boston, MA | Certificate | | Program in Clinical Effectiveness |
2004
Premio al Mejor Estudiante de Química
2005
Gran Premio Luis Stefani Rafucci, UPRM
2005
Premio del Colegio de Artes y Ciencias, UPRM
2005
Premio Antoine Laurent Lavoisier, UPRM Dept. of Chemistry
2009
Ruth L. Kirchstein Predoctoral Individual National Research Service Award (F31)
2011
NHLBI Mitochondrial Biology Symposium Travel and Oral Presentation Award
2013
Alpha Omega Alpha Honor Medical Society, Columbia University
2013
AAN Student Prize for Excellence in Neurology
2013
Doctors William Nastuk, Beatrice Seagal and Konrad Hsu Award, Columbia University
2018
NCI Paul Calabresi Clinical Oncology Award (K12)
2019
Sharpe-National Brain Tumor Society 2019-2020 GBM Research Award
2019
DF/HCC SPORE in Brain Cancer Career Enhancement Program Award
2020
Neuro-Oncology Fellowship Teacher of the Year
Research
The research activities and funding listed below are automatically derived from
NIH ExPORTER and other sources, which might result in incorrect or missing items.
Faculty can
login
to make corrections and additions.
-
78301
(Jose McFaline-Figueroa)
Jan 1, 2021 - Dec 31, 2024
Harold Amos Medical Faculty Development Program, Robert Wood Johnson Foundation
The role of CDK4/6 signaling in glioblastoma immune evasion and therapeutic resistance
Role: Principal Investigator
-
5P50CA165962
(Batchelor, Tracy)
Nov 1, 2019 - Aug 31, 2022
Integrating PI3K/Akt/mTOR inhibition and immunotherapy in glioblastoma (CEP), Project 3 Targeting CDK4/6 to Modulate the Immunogenicity in Gliomas (Div. Supp.)
Role: Career Enhancement Program awardee (11/19-8/20), NCI Diversity Supplement Investigator (9/20-8/22)
-
Sharpe-NBTS 2019-2020 GBM Research Award
(MCFALINE FIGUEROA, JOSE RICARDO)
Mar 28, 2019 - Sep 6, 2021
National Brain Tumor Society
Integrating CDK4/6 inhibition and immunotherapy for glioblastoma using humanized mouse models
Role: Principal Investigator
-
K12CA090354
(Batchelor, Tracy)
Jul 1, 2018 - Jun 30, 2020
CDK4/6 inhibition in the treatment of high-grade gliomas
-
F31AG034835
(MCFALINE FIGUEROA, JOSE RICARDO)
Aug 1, 2009 - Jul 31, 2014
Role: Principal Investigator
Bibliographic
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact contactcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.